9) Artificial enterobactin analogues and TML-based linkers as building blocks for antimicrobial siderophor-drug conjugates and development of glucosinolate-based, bioresponsive reporter molecules, 26.04.2019, Helmholtz Institut für Pharmazeutische Forschung Saarland (HIPS), Saarbrücken.

 

8) Development of natural product-based antibacterials targeting the sliding clamp DnaN (NaPAnti) - Development of novel bifunctional GM hybrid antimicrobials and conjugates, Kick-Off Meeting NaPAnti-BMBF-Project, 25.04.2019, Helmholtz Institut für Pharmazeutische Forschung Saarland (HIPS), Saarbrücken.

 

7) Development of a universal synthetic de novo access to all cytochalasan sub-classes and novel cytochalasan derivatives - A comprehensive, combinatorical approach for the exploration of the target selectivity of the cytochalasans, Initiationsmeeting DFG Researcher group Application, 12.03.2019, BMWZ, Leibnitz Universität Hannover.

 

6) Artificial enterobactin analogues and TML-based linkers as building blocks for antimicrobial siderophor-drug conjugates and development of glucosinolate-based, bioresponsive reporter molecules, 31. Irseer Naturstoff-tagung, 20.02.2019, Kloster Irsee.

 

5) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, Advances in Chemical Biology 2018, Dechema, 30.01.2018, Frankfurt am Main.

 

4) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, Bundesfachtagung (BuFaTa) Chemie, 03.11.2017. Braunschweig.

 

3) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, 21. Mitgliederversammlung des Fördervereins der Freunde des Instituts für Organische Chemie an der Technischen Universität Braunschweig e.V., 21.10.2017, Braunschweig.

 

2) Einmal Texas und zurück – Ein Weg in die Akademie, Netzwerker-Tagung der Alexander-von-Humboldt Stiftung, 20.10.2017, Bielefeld.

 

1) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, 26. Nachwuchswissenschaftler-Symposium Bioorganische Chemie, 20.09.2017, TU Berlin.